Early research (Phase 1)Study completedNCT00839631What this trial is testingDose Escalation Study of EC D-3263 HCl in Advanced Solid TumorsWho this might be right forSolid Tumors Dendreon 23
Early research (Phase 1)Study completedNCT01830816What this trial is testingPharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal ImpairmentWho this might be right forMultiple MyelomaAdvanced Solid Tumors Millennium Pharmaceuticals, Inc. 41
Testing effectiveness (Phase 2)Study completedNCT01588821What this trial is testingCabozantinib in Advanced Solid MalignanciesWho this might be right forLung CancerSolid Tumor (Not Breast or Prostate Cancers) Massachusetts General Hospital 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04266912What this trial is testingAvelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm M.D. Anderson Cancer Center 23
Early research (Phase 1)Study completedNCT03510104What this trial is testingPharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid TumorsWho this might be right forAdvanced CancerMetastatic CancerNeoplasms+3 more Meryx, Inc. 42
Testing effectiveness (Phase 2)Study completedNCT03233204What this trial is testingOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT05040932What this trial is testingStudy of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic MalignancyWho this might be right forCancer Eucure (Beijing) Biopharma Co., Ltd 8
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Early research (Phase 1)Ended earlyNCT03871855What this trial is testingSHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid TumorsWho this might be right forAdvanced Solid Tumor Jiangsu HengRui Medicine Co., Ltd. 8
Testing effectiveness (Phase 2)Looking for participantsNCT02332668What this trial is testingPembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)Who this might be right forMelanomaLymphomaSolid Tumor+2 more Merck Sharp & Dohme LLC 370
Early research (Phase 1)Ended earlyNCT00511576What this trial is testingStudy to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsWho this might be right forBreast CancerLung CancerPulmonary Cancer+5 more Mirati Therapeutics Inc. 54
Early research (Phase 1)Study completedNCT02592785What this trial is testingPhase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid TumorsWho this might be right forNeoplasms Bayer 9
Early research (Phase 1)UnknownNCT05650580What this trial is testingTR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid TumorsWho this might be right forNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma RefractoryAdvanced Solid Tumor Tarapeutics Science Inc. 26
Early research (Phase 1)Looking for participantsNCT05892718What this trial is testingA Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological TumorsWho this might be right forAdvanced Solid TumorRefractory Non-Hodgkin Lymphoma FBD Biologics Limited 80
Early research (Phase 1)Looking for participantsNCT05341557What this trial is testingBPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory LymphomaWho this might be right forAdvanced Solid TumorLymphomaNSCLC+1 more Betta Pharmaceuticals Co., Ltd. 110
Early research (Phase 1)Looking for participantsNCT05039801What this trial is testingIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsWho this might be right forAdvanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more M.D. Anderson Cancer Center 54
Early research (Phase 1)Study completedNCT01346358What this trial is testingIMC-CS4 in Subjects With Advanced Solid TumorsWho this might be right forNeoplasms Eli Lilly and Company 52
Early research (Phase 1)Study completedNCT01340040What this trial is testingDose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese SubjectsWho this might be right forCancerAdvanced Solid Malignancies AstraZeneca 10
Early research (Phase 1)Study completedNCT00207012What this trial is testingMAD Refractory: Solid Tumor QD w/o BreakWho this might be right forHER2 or EGFR Expressing Advanced Solid Malignancies Bristol-Myers Squibb 45
Early research (Phase 1)Study completedNCT00676299What this trial is testingA Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.Who this might be right forProtein Kinase InhibitorsAntineoplastic ProtocolsClinical Trial, Phase 1+4 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 19